Simple asthma drug may prevent Post-Surgery lung collapse in diabetics
NCT ID NCT07591558
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial will test whether giving a salbutamol inhaler during surgery can prevent atelectasis (partial lung collapse) in diabetic patients. Atelectasis is a common complication after chest, belly, or spine surgery. The study plans to enroll 80 adults aged 18-70 who are otherwise healthy aside from diabetes. Patients will receive 2-4 puffs of salbutamol during their operation, and doctors will check for lung collapse using vital signs, chest X-rays, and blood gas tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
salbutamol (Ventolin) inhaler
What this could lead to
If it works, this could point toward a simple, low-cost way to prevent a common post-surgery lung complication in diabetic patients.
What could go wrong
This is a very early, small trial (80 people) with no results yet. The effect may be small or not work at all, and the study only includes relatively healthy patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Abdullah University Hospital
Irbid, Jordan
Contact